Miedema F - Search Results

1

Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.

Keet IP, Krol A, Koot M, Roos MT, de Wolf F, Miedema F, Coutinho RA. Keet IP, et al. Among authors: miedema f. AIDS. 1994 Nov;8(11):1577-83. doi: 10.1097/00002030-199411000-00009. AIDS. 1994. PMID: 7848594 Clinical Trial.

2

Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.

Hazenberg MD, Otto SA, Hamann D, Roos MT, Schuitemaker H, de Boer RJ, Miedema F. Hazenberg MD, et al. Among authors: miedema f. AIDS. 2003 Jul 4;17(10):1419-24. doi: 10.1097/00002030-200307040-00001. AIDS. 2003. PMID: 12824778

3

Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, Hamann D, Prins M, Miedema F. Hazenberg MD, et al. Among authors: miedema f. AIDS. 2003 Sep 5;17(13):1881-8. doi: 10.1097/00002030-200309050-00006. AIDS. 2003. PMID: 12960820

4

Pre-seroconversion immune status predicts the rate of CD4 T cell decline following HIV infection.

van Asten L, Danisman F, Otto SA, Borghans JA, Hazenberg MD, Coutinho RA, Prins M, Miedema F. van Asten L, et al. Among authors: miedema f. AIDS. 2004 Sep 24;18(14):1885-93. doi: 10.1097/00002030-200409240-00004. AIDS. 2004. PMID: 15353974

5

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

Koot M, Vos AH, Keet RP, de Goede RE, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M. Koot M, et al. Among authors: miedema f. AIDS. 1992 Jan;6(1):49-54. doi: 10.1097/00002030-199201000-00006. AIDS. 1992. PMID: 1543566

6

Differences in clinical course in zidovudine-treated asymptomatic HIV-infected men associated with T-cell function at intake.

Gruters RA, Terpstra FG, Lange JM, Roos MT, Harkema T, Mulder JW, De Wolf F, Schellekens PT, Miedema F. Gruters RA, et al. Among authors: miedema f. AIDS. 1991 Jan;5(1):43-7. doi: 10.1097/00002030-199101000-00006. AIDS. 1991. PMID: 1676272

7

Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users.

Mientjes GH, Miedema F, van Ameijden EJ, van den Hoek AA, Schellekens PT, Roos MT, Coutinho RA. Mientjes GH, et al. Among authors: miedema f. AIDS. 1991 Jan;5(1):35-41. doi: 10.1097/00002030-199101000-00005. AIDS. 1991. PMID: 1829366

8

Immunological and virological markers in individuals progressing from seroconversion to AIDS.

Gruters RA, Terpstra FG, De Goede RE, Mulder JW, De Wolf F, Schellekens PT, Van Lier RA, Tersmette M, Miedema F. Gruters RA, et al. Among authors: miedema f. AIDS. 1991 Jul;5(7):837-44. doi: 10.1097/00002030-199107000-00007. AIDS. 1991. PMID: 1892588

9

Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 (HIV-1)-infected men.

Schellekens PT, Roos MT, De Wolf F, Lange JM, Miedema F. Schellekens PT, et al. Among authors: miedema f. J Clin Immunol. 1990 Mar;10(2):121-7. doi: 10.1007/BF00918194. J Clin Immunol. 1990. PMID: 2140115

10

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, Schellekens PT, Coutinho RA, Huisman JG, Goudsmit J, Miedema F. Tersmette M, et al. Among authors: miedema f. Lancet. 1989 May 6;1(8645):983-5. doi: 10.1016/s0140-6736(89)92628-7. Lancet. 1989. PMID: 2565516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters